RIGL Insider Trading Activity and SEC Form 4 Filings
RIGL insider trading summary
Over the past 12 months, insiders at Rigel Pharmaceuticals Inc (RIGL) reported 3 sales worth $306K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $306K.
Latest RIGL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Kamil Ali-Jackson | Insider | Sell | $88K (2,500 @ $35.00) |
| May 26, 2026 | Kamil Ali-Jackson | Insider | Sell | $73K (2,500 @ $29.17) |
| Feb 20, 2026 | Walter H Moos | Insider | Sell | $145K (4,000 @ $36.36) |
| Feb 5, 2025 | Dean L Schorno | EVP & Chief Financial Officer | Sell | $38K (1,734 @ $21.93) |
| Feb 5, 2025 | Raymond J. Furey | EVP, GC, CCO & Corp Sec | Sell | $29K (1,339 @ $21.93) |
| Feb 5, 2025 | Raul R Rodriguez | CEO, President | Sell | $96K (4,400 @ $21.93) |
| Feb 5, 2025 | David A Santos | EVP, Chief Commercial Officer | Sell | $39K (1,796 @ $21.93) |
| Feb 4, 2025 | David A Santos | EVP, Chief Commercial Officer | Sell | $44K (2,125 @ $20.92) |
| Feb 4, 2025 | Dean L Schorno | EVP & Chief Financial Officer | Sell | $43K (2,036 @ $20.92) |
| Feb 4, 2025 | Raul R Rodriguez | CEO, President | Sell | $104K (4,952 @ $20.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.